41 related articles for article (PubMed ID: 19252890)
1. Average annual cost of Parkinson's disease in a Brazilian multiethnic population.
Bovolenta TM; Schumacher-Schuh AF; Santos-Lobato BLD; Godeiro Júnior CO; Silva DJD; Nicaretta D; Barbosa ER; Cardoso FEC; Della Coletta MV; Braga Neto P; Cury RG; Tumas V; Felicio AC
Parkinsonism Relat Disord; 2023 Dec; 117():105897. PubMed ID: 37931350
[TBL] [Abstract][Full Text] [Related]
2. Economic aspects of hypertension treatment in Poland.
Krzysztoszek J; Koligat D; Ratajczak P; Bryl W; Cymerys M; Hoffmann K; Wierzejska E; Kleka P
Arch Med Sci; 2014 Jun; 10(3):607-17. PubMed ID: 25097594
[TBL] [Abstract][Full Text] [Related]
3. [Dementia and depression determine care dependency in Parkinson's disease: analysis of 1,449 outpatients receiving nursing care in Germany].
Riedel O; Dodel R; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Wittchen HU
Nervenarzt; 2011 Aug; 82(8):1012-9. PubMed ID: 21523443
[TBL] [Abstract][Full Text] [Related]
4. A review of the health-related quality of life and economic impact of Parkinson's disease.
Dowding CH; Shenton CL; Salek SS
Drugs Aging; 2006; 23(9):693-721. PubMed ID: 17020395
[TBL] [Abstract][Full Text] [Related]
5. Interventional pain management at crossroads: the perfect storm brewing for a new decade of challenges.
Manchikanti L; Singh V; Boswell MV
Pain Physician; 2010; 13(2):E111-40. PubMed ID: 20309388
[TBL] [Abstract][Full Text] [Related]
6. [Direct costs for Parkinson's treatment in private neurology practices in Berlin].
Ehret R; Balzer-Geldsetzer M; Reese JP; Dodel I; Becker E; Christopher A; Friedrich H; Kraemer S; Lüer W; Müngersdorf M; Puzich R; Rohr A; Schultes-Platzek I; Siefjediers V; Tiel-Wilck K; Oertel WH; Dodel R
Nervenarzt; 2009 Apr; 80(4):452-8. PubMed ID: 19252890
[TBL] [Abstract][Full Text] [Related]
7. Cost of illness and its predictors for Parkinson's disease in Germany.
Spottke AE; Reuter M; Machat O; Bornschein B; von Campenhausen S; Berger K; Koehne-Volland R; Rieke J; Simonow A; Brandstaedter D; Siebert U; Oertel WH; Ulm G; Dodel R
Pharmacoeconomics; 2005; 23(8):817-36. PubMed ID: 16097843
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany.
Winter Y; Balzer-Geldsetzer M; Spottke A; Reese JP; Baum E; Klotsche J; Rieke J; Simonow A; Eggert K; Oertel WH; Dodel R
Eur J Neurol; 2010 Sep; 17(9):1156-1163. PubMed ID: 20345926
[TBL] [Abstract][Full Text] [Related]
9. Costs of Parkinson's disease in eastern Europe: a Czech cohort study.
Winter Y; von Campenhausen S; Brozova H; Skoupa J; Reese JP; Bötzel K; Eggert K; Oertel WH; Dodel R; Ruzicka E
Parkinsonism Relat Disord; 2010 Jan; 16(1):51-6. PubMed ID: 19665915
[TBL] [Abstract][Full Text] [Related]
10. Costs of illness and care in Parkinson's disease: an evaluation in six countries.
von Campenhausen S; Winter Y; Rodrigues e Silva A; Sampaio C; Ruzicka E; Barone P; Poewe W; Guekht A; Mateus C; Pfeiffer KP; Berger K; Skoupa J; Bötzel K; Geiger-Gritsch S; Siebert U; Balzer-Geldsetzer M; Oertel WH; Dodel R; Reese JP
Eur Neuropsychopharmacol; 2011 Feb; 21(2):180-91. PubMed ID: 20888737
[TBL] [Abstract][Full Text] [Related]
11. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.
Wang G; Cheng Q; Zheng R; Tan YY; Sun XK; Zhou HY; Ye XL; Wang Y; Wang Z; Sun BM; Chen SD
Mov Disord; 2006 Sep; 21(9):1439-43. PubMed ID: 16773620
[TBL] [Abstract][Full Text] [Related]
12. Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study.
Reuther M; Spottke EA; Klotsche J; Riedel O; Peter H; Berger K; Athen O; Köhne-Volland R; Dodel RC
Parkinsonism Relat Disord; 2007 Mar; 13(2):108-14. PubMed ID: 17055326
[TBL] [Abstract][Full Text] [Related]
13. [Prospective study of the direct and indirect costs of idiopathic Parkinson's disease].
Dengler I; Leukel N; Meuser T; Jost WH
Nervenarzt; 2006 Oct; 77(10):1204-9. PubMed ID: 17004081
[TBL] [Abstract][Full Text] [Related]
14. [Cost and quality aspects in the treatment of Parkinson's disease].
Müller T; Dodel R; Fritze J
Z Arztl Fortbild Qualitatssich; 2006; 100(4):291-5. PubMed ID: 16878798
[TBL] [Abstract][Full Text] [Related]
15. Quality of life and depression in Parkinson's disease.
Schrag A
J Neurol Sci; 2006 Oct; 248(1-2):151-7. PubMed ID: 16797028
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
